InvestSMART

Colonial Managed Investment Funds - Global Health & Biotech - Managed Fund

Fund Objective
The fund's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The fund does not hedge currency risk.
Fund Strategy
The fund's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The fund does not hedge currency risk.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return -4.63% 1.77% 14.15% -1.21% 3.7% 7.38% 5.67% 8.02%
Growth return -2.68% 13.98% 18.05% 7.89% 8.88% 7.33% 6.99% 7.29%
Income return -1.95% -12.21% -3.9% -9.1% -5.18% 0.05% -1.32% 0.73%
Market index (MSCI World Ex Australia NR AUD)
Total return -0.9% 2.55% 8.85% 12.53% 21.5% 22.08% 15.57% 13.23%
As at 31 Jan 2026. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Colonial Managed Investment Funds - Global Health & Biotech
Australian Equities
97.13%
Cash
2.87%
International Equities
0%
Property & Infrastructure
0%
Fixed Interest
0%
Alternatives
0%
Average Allocation of Peers
Australian Equities
64.54%
Cash
1.25%
International Equities
33.72%
Property & Infrastructure
0.24%
Fixed Interest
-0.01%
Alternatives
0.26%

General Information

Fund Details
Type Description
Colonial Managed Investment Funds - Global Health & Biotech
Colonial First State Investments Limited
FSF0145AU
Equity World Other
Not Rated
Investment Fund
1 May 2000
$33717799 million (as at 31 Dec 2025)
$4.4981 (as at 28 Jan 2026)
$4.4891 (as at 28 Jan 2026)
Open
Offer information
Type Description
Standard entry fee 4%
MER 1.20% (as at 22 Nov 2025)
Indirect Cost Ratio (ICR) 1.20% (as at 30 Jun 2025)
Minimum initial investment $1,000.00
Minimum additional investments
Minimum redemption amount

Top 10 holdings (as at 31 Dec 2025)

Holding (as at 31 Dec 2025) Type % of Portfolio
Eli Lilly and Co Equity 9.44%
Login now to view the complete list of holdings.
Your guide to next steps

Dealing with a struggling fund? What to Do and Look For

How to Assess your Managed Fund: And How to Choose the Next One
How to Assess your Managed Fund: And How to Choose the Next One
Your managed fund switching checklist. Is fear of capital gains tax holding you back?
Your managed fund switching checklist. Is fear of capital gains tax holding you back?
The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.
The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.
Guide to tidying up your Portfolio Manager holdings
Guide to tidying up your Portfolio Manager holdings

FAQs about the Colonial Managed Investment Funds - Global Health & Biotech

The objective of the Colonial Managed Investment Funds - Global Health & Biotech managed fund is The fund's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The fund does not hedge currency risk.

The strategy of the Colonial Managed Investment Funds - Global Health & Biotech managed fund is The fund's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The fund does not hedge currency risk.

The APIR code of the Colonial Managed Investment Funds - Global Health & Biotech managed fund is FSF0145AU.

Colonial Managed Investment Funds - Global Health & Biotech’s total return last month was -4.63%. This was made up of a growth return of -2.68% and an income return of -1.95%. These returns were calculated as at 31 Jan 2026.

Colonial Managed Investment Funds - Global Health & Biotech’s total return for the last three months was 1.77%. This was made up of a growth return of 13.98% and an income return of -12.21%%. These returns were calculated as at 31 Jan 2026.

Colonial Managed Investment Funds - Global Health & Biotech’s one-year total return is -1.21%. This was made up of a growth return of 7.89% and an income return of -9.1%. These returns were calculated as at 31 Jan 2026.

Colonial Managed Investment Funds - Global Health & Biotech’s one-year total return is 7.38%. This was made up of a growth return of 7.33% and an income return of 0.05%. These returns were calculated as at 31 Jan 2026.

The asset allocation of the Colonial Managed Investment Funds - Global Health & Biotech managed fund is :

Australian Equities
97.13%
Cash
2.87%
International Equities
0%
Property & Infrastructure
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the Colonial Managed Investment Funds - Global Health & Biotech managed fund is Colonial First State Investments Limited.

The Colonial Managed Investment Funds - Global Health & Biotech managed fund belongs to the Equity World Other sector/asset class.

As at 31 Dec 2025, the size of the Colonial Managed Investment Funds - Global Health & Biotech managed fund was $33717799 million.

The Colonial Managed Investment Funds - Global Health & Biotech managed fund has an inception date of 1 May 2000.

The current entry price of the Colonial Managed Investment Funds - Global Health & Biotech managed fund is $4.4981 per unit and the current exit price is $4.4891 per unit (as at 28 Jan 2026).

The current exit price of the Colonial Managed Investment Funds - Global Health & Biotech managed fund is $4.4891 per unit and the current entry price is $4.4981 per unit (as at 28 Jan 2026).

The minimum initial investment amount for the Colonial Managed Investment Funds - Global Health & Biotech managed fund is $1,000. Minimum additional investment is $0.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.